Avantor Services provides a wide range of specialized services and digital solutions to help you solve complex challenges.
We’ve built our reputation on consistent, comprehensive mastery of day-to-day operations, allowing lab, clinical, and production environments to focus their high-value resources on core scientific priorities.
As our customers’ needs have evolved, so have our capabilities. We have become experts in scientific operations, improving performance with sophisticated solutions and providing guidance on best practices.
You can select and customize services for peak efficiency, quality, and accelerated innovation.
FROM MOLECULE DISCOVERY TO COMPLETE FILL AND FINISH
Each stage of bioprocessing is influenced by the steps preceding it. You're constantly striving to achieve higher production yields, which influence manufacturing costs. The following considerations are important to weigh:
Selecting the correct expression system
Choosing the right medium and feed for your bioreactor to achieve maximum cell density and productivity
Capturing, clarifying, and concentrating the target protein efficiently
Obtaining the purified protein through downstream processes
Packaging the protein formulation during final fill in the required configuration
Avantor’s bioprocessing solutions focus on what matters most for your operations. We provide a unique combination of industry expertise with the broadest portfolio of products and materials engineered and manufactured to satisfy the highest quality standards and regulatory requirements for your final product – whether it is a vaccine, monoclonal antibody, recombinant protein, cell therapy, or gene therapy.
As Avantor’s channel brand, VWR, part of Avantor provides you with an integrated, seamless purchasing experience that is optimized for the way you do business. Access top industry brands through VWR, part of Avantor for an even broader selection of media components, animal sera, buffers, process biochemicals, excipients and single-use solutions to address upstream and downstream processes as well as final fill formulations.
Interview with Ger Brophy, Avantor’s Executive Vice President for Biopharma Production
Opportunities and challenges in cell and gene therapy development